To view this, you need to install the Flash Player 5. Please go to here and download it.

Personal Injury Blog

Jerry Lindheim on the Afternoon Drive show on WPHT 1210AM regarding Nursing Home Abuse

April 10, 2014 @ 04:29 PM — by Admin
Tagged with:

On the 21st day of March,  Jerry Lindheim, Esquire-partner at the Locks Law Firm was featured on the Dick Morris Afternoon Drive radio broadcast WPHT 1210AM during which time he discussed nursing home neglect and abuse and patient's rights and remedies.  

http://www.podtrac.com/pts/redirect.mp3/nyc.podcast.play.it/media/d0/d0/d1/d4/dV/dU/dQ/14VUQ_3.MP3

Risperdal Cases

February 28, 2014 @ 12:11 PM — by Leon Carpenter
Tagged with: Risperdal

Locks Law Firm announces it is now accepting Risperdal cases.

Zimmer Durom Cup Hip Replacement Cases

February 28, 2014 @ 12:04 PM — by Leon Carpenter

Locks Law Firm announces it is now accepting Zimmer Durom cup hip replacement cases.

Locks Law Firm announces it is handling claims against the manufacturers and distributors of testosterone-based products

February 09, 2014 @ 08:27 PM — by Leon Carpenter

Last week the U.S. Food and Drug Administration said it has begun investigating the risk of stroke, heart attack and death in men taking prescription testosterone drugs.

The announcement came on the heels of two recent two studies that suggested an increased risk of heart attacks in men who take testosterone, a hormone produced in the testicles that is responsible for maintaining muscle bulk, bone growth and sexual function, the FDA said. The FDA said it has not concluded that testosterone increases the risk of cardiac events but said it is issuing an alert "while we continue to evaluate the information from these studies and other available data."

Actos trial involves claim that Takeda destroyed files

January 30, 2014 @ 09:47 AM — by Admin

The first Actos trial in the federal MDL (Multi-District Litigation) system began this week in Louisiana. Federal Judge Rebecca Doherty ruled that the leadership demonstrated by Takeda (the maker of Actos) regarding files that were lost, deleted or destroyed was disturbing. The judge therefore ruled that plaintiffs' lawyers could tell jurors about the document destruction. Takeda is the largest drug company in Asia. Actos is a diabetes drug that causes bladder cancer. Sales of Actos peaked in March 2011 at $4.5 billion and accounted for 27% of Takeda's revenue at that point. Since Actos was released in 1999 it has generated over $16 billion in sales. If you or a loved one used Actos and developed bladder cancer contact Locks Law Firm on our TOLL FREE line to discuss if we can help you. 866-LOCKSLAW  (866-562-5752) 

Actos Trial Begins

January 28, 2014 @ 03:32 PM — by Admin

A jury was selected yesterday in the Allen trial, in the federal MDL (Multi-District Litigation)  in Louisiana, consisting of 7 women and 2 men. Opening arguments are scheduled for Monday, February 3rd. This will be the fourth trial. Two were wins for plaintiffs but the judge in each case overturned the verdict for plaintiffs. The third was a defense verdict. Actos is a diabetes drug that causes bladder cancer. If you or a loved onE took Actos and have been diagnosed with bladder cancer, please call our TOLL FREE number - 866-LOCKSLAW (866-562-5752).

Byetta/Januvia Lawsuits Centralized in MDL 2452

October 28, 2013 @ 02:29 PM — by Admin
Tagged with: Fda Byetta Januvia Victoza

Byetta is a popular injectable-type drug, sold by Bristol-Myers Squibb (after it bought Amlyn Pharmacueticals which had been making it) for patients with Type-2 diabetes. Januvia is another one, sold by Merck. Other related drugs are Victoza (liraglutide) and also a form of Januvia called Janumet (sitagliptin combined with metaformin sold by Merck.  Victoza is sold by Novo Nordisk. The drugs are sometimes called incretin mimetics. These drugs seem to work by mimicking the incretin hormone GLP-1 that the body usually produces naturally to stimulate the release of insulin in response to eating a meal, and/or by inhibiting the effect the enzyme DPP-4. (cont.)

Actos Litigation Heats Up

October 28, 2013 @ 11:23 AM — by Admin
Tagged with: Actos Pharmaceuticals

There are now more than 2,625 Actos cases filed in the Multi-District Litigation ("MDL") in Louisiana federal court. Defendants have produced to plaintiffs over 40 million pages of documents. About 45 depositions of experts and fact witnesses have been taken. The Honorable Rebecca Doherty expects the first "bellwether" trial to be in January 2014.

So far there have two jury verdicts, both in favor of the injured plaintiffs, but both have been overturned by the trial judge. (cont.)

Spinal Meningitis Update

October 25, 2013 @ 09:54 AM — by Admin

Remember the 2012 outbreak of spinal meningitis among patients receiving steroid spinal injections that were contaminated? The patients in New Jersey who were contaminated received drugs compounded by NECCin New England. Now, New Jersey Congressman Frank Pallone has co-authored a bill to allow the FDA to require higher standards for certain drugs, and to clarify current federal law regarding traditional pharmacy compounding to apply a uniform standard nationwide....

A Message From The Locks Law Firm - Proposed NFL Concussion Litigation Settlement

August 29, 2013 @ 04:32 PM — by Admin

The NFL and the retired players have reached a proposed settlement of the NFL Players’ Concussion Injury Litigation. Under the proposed settlement, which the Court (Hon. Anita B. Brody) must analyze for fairness, reasonableness, and adequacy, the NFL has agreed to pay close to $800 million to the retired NFL players and their families, in addition to any NFL benefits they have received or will receive in the future. The settlement includes a medical testing program (called the Baseline Assessment Program or BAP) which is independent of the NFL and financed by the proposed settlement.  It is for all retired NFL players and provides neurological medical attention and care to retired players. (cont.)

Share |

Back to top